DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
DALS was delisted on the 28th of July, 2023.
35 hedge funds and large institutions have $163M invested in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in 2021 Q3 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$30.6M |
| 2 |
DM
Deerfield Management
New York
|
+$15.8M |
| 3 |
BlackRock
New York
|
+$14.8M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$14.8M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$9.88M |
Top Sellers
DALS Hedge Fund Activity: Q3 2021 in Review
35 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q3 2021, worth a combined $163M.
Buyers outnumbered sellers: 35 funds opened new DALS positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $30.6M.
- 35 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $163M of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q3 2021.
- 35 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q3 2021 and 0 closed out, a net change of +35 holders.
- The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock buyer in Q3 2021 was Wellington Management Group, an estimated $30.6M added.
Based on aggregated 13F filings for Q3 2021.